Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,724.00
Bid: 2,722.00
Ask: 2,726.00
Change: -18.00 (-0.66%)
Spread: 4.00 (0.147%)
Open: 2,746.00
High: 2,754.00
Low: 2,714.00
Prev. Close: 2,742.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Supplementary Base Prospectus dated November 11, 2

11 Nov 2014 13:32

RNS Number : 7275W
Coca-Cola HBC Finance B.V.
11 November 2014
 



 

Coca-Cola HBC Finance B.V.

Guaranteed by Coca-Cola HBC AG and Coca-Cola HBC Holdings B.V.

announce the publication of supplementary prospectus relating to the

EUR 3,000,000,000 Euro Medium Term Note Programme of Coca-Cola HBC Finance B.V.

 

 

Amsterdam The Netherlands - November 11, 2014 - Coca-Cola HBC Finance B.V., Coca-Cola HBC AG and Coca-Cola HBC Holdings B.V. announce today the publication of the following supplementary prospectus which has been approved by the UK Listing Authority and is available for viewing:

 

Supplementary Prospectus, dated November 11, 2014 to the Base Prospectus dated September 18, 2014, in respect of the €3,000,000,000 Euro Medium Term Note Programme of Coca-Cola HBC Finance B.V. as issuer and Coca-Cola HBC A.G. and Coca-Cola HBC Holdings B.V. as guarantors (the "Supplementary Prospectus").

 

The Supplementary Prospectus constitutes a supplement for the purposes of Section 87G of the Financial Services and Markets Act 2000 (the "FSMA").This Supplement is supplemental to, and should be read in conjunction with, the Base Prospectus dated September 18, 2014. Terms defined in the Base Prospectus have the same meaning when used in this Supplement. The purpose of this Supplement is to incorporate by reference in the Base Prospectus the CCH Group's third quarter results for the period ended 26 September 2014 (the "CCH Group Results").

 

Copies of the CCH Group Results have been filed with the Financial Conduct Authority and, by virtue of this Supplement, the CCH Group Results are incorporated in, and form part of, the Base Prospectus, save that the ninth paragraph on page twelve of the CCH Group Results shall not be deemed to be incorporated in and shall not be deemed to form part of this Supplement.

 

A copy of the Supplementary Prospectus and the CCH Group Results have also been submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM.

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Supplementary Prospectus (and the Base Prospectus to which it relates) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Supplementary Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirements.

 

This announcement shall not constitute an offer to sell or a solicitation of an offer to buy the notes or any other securities. The notes under this Euro Medium Term Note Programme will not be registered under the United States Securities Act of 1933 (as amended) and, subject to certain exceptions, may not be offered, sold or delivered within the United States or to or for the account or benefit of U.S. persons.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIBBBJTMBTBBLI
Date   Source Headline
6th Jun 20229:32 amRNSHolding(s) in Company
1st Jun 202210:02 amRNSIssue of Equity
31st May 20225:17 pmRNSLetter to shareholders
19th May 20229:20 amRNSNotice of AGM
18th May 20223:05 pmRNSDirector/PDMR Shareholding
18th May 202212:24 pmRNSHolding(s) in Company
12th May 20227:00 amRNSStrong performance despite turbulent environment
3rd May 202210:22 amRNSIssue of equity and total voting rights
3rd May 202210:05 amRNSBlock listing Interim Review
29th Apr 20221:46 pmRNSHolding(s) in Company
20th Apr 20223:03 pmRNSDirector/PDMR Shareholding
19th Apr 202210:06 amRNSNotice of Results
12th Apr 20225:38 pmRNSMove to organic reporting
1st Apr 20223:58 pmRNSDirector/PDMR Shareholding
1st Apr 20223:47 pmRNSDirector/PDMR Shareholding
1st Apr 202211:46 amRNSIssue of equity and total voting rights
23rd Mar 202212:23 pmRNSAnnual Financial Report
18th Mar 20222:02 pmRNSDirector/PDMR Shareholding
16th Mar 20223:43 pmRNSDirector/PDMR Shareholding
16th Mar 202212:56 pmRNSDirector/PDMR Shareholding
14th Mar 202210:57 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSUkraine and Russia update
3rd Mar 20224:31 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSUkraine and Russia conflict update
22nd Feb 20227:00 amRNSSTRONG EXECUTION DRIVES GROWTH MOMENTUM
18th Feb 20222:45 pmRNSDirector/PDMR Shareholding
2nd Feb 20229:57 amRNSNotice of Results
1st Feb 20228:20 amRNSIssue of equity and total voting rights
25th Jan 202212:50 pmRNSCompletes acquisition of further stake in CCBCE
18th Jan 20222:20 pmRNSDirector/PDMR Shareholding
13th Jan 20228:53 amRNSCompletes acquisition of a majority stake in CCBCE
7th Jan 20222:14 pmRNSAthens Exchange trading date of ordinary shares
4th Jan 202210:55 amRNSIssue of equity and total voting rights
4th Jan 20229:54 amRNSDirector/PDMR Shareholding
31st Dec 202110:27 amRNSDirector/PDMR Shareholding
31st Dec 202110:19 amRNSDirector/PDMR Shareholding
20th Dec 20213:58 pmRNSDirector/PDMR Shareholding
20th Dec 20213:43 pmRNSDirector/PDMR Shareholding
17th Dec 20213:38 pmRNSPost 2021 AGM Shareholder Engagement
13th Dec 20213:29 pmRNSDirector/PDMR Shareholding
7th Dec 202110:29 amRNSDirector/PDMR Shareholding
1st Dec 20218:34 amRNSIssue of equity and total voting rights
18th Nov 20211:12 pmRNSDirector/PDMR Shareholding
15th Nov 20213:16 pmRNSDirector/PDMR Shareholding
15th Nov 20212:03 pmRNSDirector/PDMR Shareholding
12th Nov 20219:17 amRNSDirector/PDMR Shareholding
12th Nov 20218:45 amRNSDirector/PDMR Shareholding
11th Nov 202111:57 amRNSDirector/PDMR Shareholding
3rd Nov 20217:00 amRNSFocused strategy drives acceleration in growth
1st Nov 20219:18 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.